Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies

Am J Obstet Gynecol. 2008 Dec;199(6):653.e1-10. doi: 10.1016/j.ajog.2008.06.030. Epub 2008 Aug 22.

Abstract

Objective: The objective of the study was to determine whether blood pressure increases are associated with maternal angiogenic factors in uncomplicated and preeclamptic pregnancies.

Study design: Associations of blood pressure increases from mid- to late pregnancy with maternal serum concentrations of soluble fms-like tyrosine kinase receptor (sFlt1), soluble endoglin (sEng), and placental growth factor (PlGF) at delivery were analyzed in 43 uncomplicated and 44 preeclamptic pregnancies.

Results: In uncomplicated pregnancies, increases in diastolic and mean arterial pressure were inversely associated with PlGF at delivery and positively associated with sEng and sFlt1/PlGF ratio. There were no significant associations between blood pressure increases and angiogenic factor concentrations in preeclampsia.

Conclusion: These data suggest that angiogenic factors are involved in blood pressure modulation in normotensive pregnancy and are consistent with the hypothesis that angiogenic balance plays a role in maternal breast cancer risk reduction associated with mid- to late blood pressure increases in uncomplicated pregnancies.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Angiogenesis Inducing Agents / analysis
  • Angiogenesis Inducing Agents / blood
  • Angiogenic Proteins / analysis
  • Angiogenic Proteins / blood*
  • Biomarkers / blood
  • Blood Pressure Determination
  • Case-Control Studies
  • Cesarean Section / statistics & numerical data
  • Delivery, Obstetric / methods
  • Female
  • Humans
  • Hypertension / blood
  • Hypertension / complications
  • Hypertension / diagnosis*
  • Linear Models
  • Placenta Growth Factor
  • Pre-Eclampsia / blood*
  • Pre-Eclampsia / diagnosis
  • Pregnancy
  • Pregnancy Outcome*
  • Pregnancy Proteins / blood
  • Pregnancy Trimester, Second
  • Pregnancy Trimester, Third
  • Probability
  • Reference Values
  • Risk Assessment
  • Sensitivity and Specificity
  • Vascular Endothelial Growth Factor Receptor-1

Substances

  • Angiogenesis Inducing Agents
  • Angiogenic Proteins
  • Biomarkers
  • PGF protein, human
  • Pregnancy Proteins
  • Placenta Growth Factor
  • Vascular Endothelial Growth Factor Receptor-1